Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
16°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aprea Therapeutics Inc
(NQ:
APRE
)
2.923
UNCHANGED
Streaming Delayed Price
Updated: 10:47 AM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aprea Therapeutics Inc
< Previous
1
2
3
4
5
6
Next >
Aprea Therapeutics Announces Pricing of $5.5 Million Underwritten Public Offering of Common Stock
February 22, 2023
From
Aprea Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 22, 2023
Via
Benzinga
Aprea Therapeutics Announces Proposed Public Offering of Common Stock
February 22, 2023
From
Aprea Therapeutics
Via
GlobeNewswire
Aprea Therapeutics Announces Phase II SBIR Award from the National Cancer Institute (NCI)
February 15, 2023
From
Aprea Therapeutics
Via
GlobeNewswire
Aprea Therapeutics Announces One-for-Twenty Reverse Stock Split
February 13, 2023
From
Aprea Therapeutics
Via
GlobeNewswire
Aprea Therapeutics Appoints John Hamill as Chief Financial Officer
January 30, 2023
From
Aprea Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
January 19, 2023
Via
Benzinga
Aprea Therapeutics to Participate in 6th Annual DNA Damage and Response (DDR) Inhibitors Summit
January 19, 2023
From
Aprea Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 11, 2023
Via
Benzinga
Aprea Therapeutics Announces Dosing of First Patient in Phase 1/2a Clinical Trial of Oral ATR Inhibitor ATRN-119 for the Treatment of Advanced Solid Tumors
January 11, 2023
From
Aprea Therapeutics
Via
GlobeNewswire
Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 05, 2023
Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 07, 2022
Via
Benzinga
Why Iovance Biotherapeutics Shares Are Trading Higher By Around 19%? Here Are 40 Stocks Moving In Monday's Mid-Day Session
December 05, 2022
Gainers Winc, Inc. (NYSE: WBEV) rose 88.5% to $0.3901 after dropping over 23% on Friday. Winc, last month, posted a Q3 loss of $0.33 per share.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 11, 2022
Gainers
Via
Benzinga
Aprea Therapeutics Reports Third Quarter 2022 Financial Results and Provides Update on Business Operations
November 09, 2022
From
Aprea Therapeutics
Via
GlobeNewswire
Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday
November 14, 2022
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday.
Via
Benzinga
Why Compass Shares Are Trading Higher By Over 56%? Here Are 63 Stocks Moving In Friday's Mid-Day Session
November 11, 2022
Gainers Snail, Inc. (NASDAQ: SNAL) shares jumped 74.9% to $3.9350 after the company announced a $5 million share repurchase program.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 13, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
November 11, 2022
On Friday, 63 stocks hit new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 22, 2022
Via
Benzinga
Aprea Therapeutics: Q2 Earnings Insights
August 12, 2022
Aprea Therapeutics (NASDAQ:APRE) reported its Q2 earnings results on Friday, August 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Aprea Therapeutics posted...
Via
Benzinga
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
September 14, 2022
Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX...
Via
Benzinga
This Financial Services Stock Is Trading Higher By 50%, Here Are 40 Stocks Moving In Tuesday's Mid-Day Session
July 19, 2022
Gainers Applied Blockchain, Inc. (NASDAQ: APLD) jumped 50.1% to $1.5907 after the company reported a 200-megawatt five-year hosting contract with Marathon Digital Holdings and raised its Q4 revenue...
Via
Benzinga
Why Amazon, Microsoft, Apple Shares Are Trading Lower, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session
September 13, 2022
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 186% to $47.69 as the stock started trading on a 1-for-30 reverse split basis.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
July 18, 2022
Via
Benzinga
Short Volatility Alert: Aprea Therapeutics, Inc.
July 13, 2022
On Tuesday, shares of Aprea Therapeutics, Inc. (NASDAQ: APRE) experienced volatile short activity. After the activity, the stock price went up +5.14% to $0.94. The overall sentiment for APRE has been...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 11, 2022
Via
Benzinga
Tesla, Twitter And 76 Biggest Movers From Friday
July 11, 2022
Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board...
Via
Benzinga
Aprea Therapeutics (APRE) Stock Soars as Wedbush Sets $3 Price Target
July 08, 2022
Wedbush analyst Robert Driscoll just gave a huge upside target for APRE stock. Here’s why this is significant for the biotech sector.
Via
InvestorPlace
Tesla, WD-40 Company And 40 Stocks Moving In Friday's Mid-Day Session
July 08, 2022
Gainers Aditxt, Inc. (NASDAQ: ADTX) shares surged 75.7% to $0.2812 after the company's Adimune therapeutic program completed a toxicology study indicating a favorable safety profile of ADI-100.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.